Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
Not Applicable
Terminated
- Conditions
- Retinopathy.The Mechanism of Retinal Neovascularization of Diabetic
- Interventions
- Genetic: genetic analyzer
- Registration Number
- NCT01229540
- Lead Sponsor
- Tianjin Medical University
- Brief Summary
Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
- DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
- All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.
Exclusion Criteria
- Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Lifestyle counseling genetic analyzer -
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Tianjin Eye Hospital, Clinical college of Ophthalmology ,Tianjin Medical Univercity
🇨🇳Tianjin, Tianjin, China